Cancer, Vulnerability, and Financial Quality of Life: A Mixed Methods Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary purpose of this study is to examine how vulnerabilities in psychological and social situations affect financial quality of life. For people who are experiencing financial hardship, a cancer diagnosis can be devastating. For others, cancer may cause or even worsen financial stress, for example, with their work, their ability to maintain benefits such as health insurance, their ability to pay bills, and their ability to get the cancer treatment they need. The impact of cancer on financial quality of life is an important area of study within cancer care. Considering the financial burden of cancer also lends greater appreciation for the problems that people face if they cannot handle cancer's costs, or if needed resources are either not present or are too stretched to help with the care they need. For this study, up to 180 cancer patients will be interviewed with a written questionnaire. Of this group, 15 people will also be asked if they would like to participate in a follow-up personal interview with the researcher. The major hypothesis of this study is: The greater the vulnerabilities in predisposing factors and enabling factors, the greater the need factors with respect to cancer diagnosis and treatment, and the lower the perceived ability to adhere to treatment, the poorer will be the financial quality of life.
| Condition |
|---|
|
Cancer |
| Study Type: | Observational |
| Study Design: | Time Perspective: Cross-Sectional |
| Official Title: | Cancer, Vulnerability, and Financial Quality of Life: A Mixed Methods Study |
- The secondary purpose is to explore qualitatively the relationship between personal control and financial quality of life within the larger context of health locus of control [ Time Frame: December 2010 ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 180 |
| Study Start Date: | May 2010 |
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Cancer patients over the age of 18 |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Any cancer patient over the age of 18 who can speak and understand English and can provide informed consent
Inclusion Criteria:
- Any cancer patient over the age of 18 who can speak and understand English and can provide informed consent
Exclusion Criteria:
- Pediatric patients; non-English-speaking patients
Contacts and Locations| United States, District of Columbia | |
| Washington Cancer Institute | |
| Washington, DC, District of Columbia, United States, 20010 | |
| United States, Maryland | |
| NIH Clinical Center | |
| Bethesda, Maryland, United States, 20892 | |
| Principal Investigator: | Christine C. Callahan, MSW | The Catholic University of America |
More Information
No publications provided
| Responsible Party: | Christine Callahan, MSW, LCSW-C, clinical social worker and PhD candidate, Georgetown University |
| ClinicalTrials.gov Identifier: | NCT01169545 History of Changes |
| Other Study ID Numbers: | 2010-090 |
| Study First Received: | July 22, 2010 |
| Last Updated: | March 8, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Georgetown University:
|
any type of cancer |
ClinicalTrials.gov processed this record on May 22, 2013